NASHVILLE, Tenn., Feb. 23, 2024 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced today that Company management will participate in Citi's 2024 Global Property CEO Conference on March 4, 2024 and Barclays Global Healthcare Conference on March 12, 2024.
On March 4, at the Citi Conference, the Brookdale roundtable presentation will begin at 6:30 am CST, and the live webcast can be accessed through the Company's website at brookdaleinvestors.com as well as by clicking here.
On March 12, at the Barclays Conference, the Brookdale fireside chat will begin at 12:35 pm CST, and the live webcast can be accessed through the Company's website as well as by clicking here.
A replay of the webcasts will be available on the Company's website until April 12, 2024.
About Brookdale Senior Living
Brookdale Senior Living Inc. is the nation's premier operator of senior living communities. The Company is committed to its mission of enriching the lives of the people it serves with compassion, respect, excellence, and integrity. The Company, through its affiliates, operates independent living, assisted living, memory care, and continuing care retirement communities. Through its comprehensive network, Brookdale helps to provide seniors with care, connection, and services in an environment that feels like home. The Company's expertise in healthcare, hospitality, and real estate provides residents with opportunities to improve wellness, pursue passions, make new friends, and stay connected with loved ones. Brookdale, through its affiliates, operates and manages 652 communities in 41 states as of December 31, 2023, with the ability to serve approximately 59,000 residents. Brookdale's stock trades on the New York Stock Exchange under the ticker symbol BKD. For more information, visit brookdale.com or connect with Brookdale on Facebook or YouTube.
Last Trade: | US$7.49 |
Daily Change: | 0.30 4.17 |
Daily Volume: | 2,234,826 |
Market Cap: | US$1.420B |
March 08, 2024 January 09, 2024 December 08, 2023 November 06, 2023 |
Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB